B-cell chronic lymphocytic leukemia: A bird of a different feather

Journal of Clinical Oncology

Volumn 17, Issue 1, 1999, Pages 399-408

  Caligaris Cappio, Federico ^a   Hamblin, Terry J ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; CYTOKINE; LYMPHOCYTE ANTIGEN RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; AUTOIMMUNITY; B CELL LEUKEMIA; CHROMOSOME 12Q; CHROMOSOME 13Q; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNE DEFICIENCY; IMMUNOGLOBULIN GENE; IMMUNOPHENOTYPING; PRIORITY JOURNAL; REVIEW; TRISOMY;

EID: 0032941221     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.1.399     Document Type: Review

References (125)

1. Hamblin TJ, Oscier DG: Chronic lymphocytic leukemia, in Whittaker JA, Holmes J (eds): Leukaemia and Associated Diseases. Oxford, UK, Blackwell Science, 1998, pp 105-135
2. Kipps T, Carson DA: Autoantibodies in chronic lymphocytic leukemia and related systemic autoimmune diseases. Blood 81:2475-2487, 1993
3. Rozman C, Montserrat E: Chronic lymphocytic leukemia. N Engl J Med 333:1052-1057, 1995
4. Caligaris-Cappio F, Janossy G: Surface markers in chronic lymphoid leukemias of B cell type. Semin Hematol 22:1-12, 1985
5. Boumsell L, Bernard A, Lepage V, et al: Some chronic lymphocytic leukemia cells bearing surface immunoglobulins share determinants with T cells. Eur J Immunol 8:900-904, 1978
6. Ternynck T, Dighiero G, Follezou JY, et al: Comparison of normal and CLL lymphocyte surface Ig determinants using peroxidase-labeled antibodies. I. Detection and quantitation of light chain determinants. Blood 43:789-795, 1974
7. Hashimoto S, Dono M, Watai M, et al: Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+, CD5+ chronic lymphocytic leukemia B cells. J Exp Med 181:1507-1517, 1995
8. Preud'homme JL, Seligmann M: Anti-human immunoglobulin G activity of membrane-bound immunoglobulin M in lymphoproliferative disorders. Proc Natl Acad Sci USA 69:2132-2135, 1972
9. Borche L, Lim A, Binet JL, et al: Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. Blood 76:5625-5669, 1990
10. Sthoeger ZM, Wakai M, Tse DB, et al: Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med 169:255-268, 1989
11. Kipps TJ, Tomhave E, Pratt LF, et al: Developmentally restricted VH gene expressed at high frequency in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 86:5913-5917, 1989
12. Schroeder HW, Dighiero G: The pathogenesis of chronic lymphocytic leukemia: Analysis of the antibody repertoire. Immunol Today 15:288-294, 1994
13. Harris NL, Jaffe ES, Stein H, et al: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361-1392, 1994
14. Goodnow CC, Crosbie J, Adelstein S, et al: Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 334:676-682, 1988
15. Caligaris-Cappio F, Gobbi M, Bofill M, et al: Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med 155:623-628, 1982
16. Casali P, Notkins AL: Probing the human B-cell repertoire with EBV: Polyreactive antibodies and CD5+ B lymphocytes. Annu Rev Immunol 7:513-525, 1989
17. Kipps TJ, Duffy SF: Relationship of the CD5 B cell to human tonsillar B lymphocytes that express autoantibody-associated cross-reactive idiotypes. J Clin Invest 87:2087-2096, 1991
18. Caligaris-Cappio F: B-chronic lymphocytic leukemia: A malignancy of anti-self B cells. Blood 87:2615-2620, 1996
19. Kobayashi R, Rassenti LZ, Meisenholder G, et al: Autoantigen inhibits apoptosis of a human B cell leukemia that produces pathogenic rheumatoid factor. J Immunol 151:7273-7283, 1993
20. Fournier S, Rubio M, Delespesse G, et al: Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood 84:1881-1886, 1994
21. Stathopoulos G, Elliot EV: Formation of mouse and sheep red-blood cell rosettes by lymphocytes from normal and leukaemic individuals. Lancet 1:600-602, 1974
22. Morabito F, Prasthofer EF, Dunlap, et al: Expression of myelomonocytic antigens on chronic lymphocytic leukemia B cells correlates with their ability to produce interleukin 1. Blood 70:1750-1757, 1987
23. Andreeff M, Darzynkiewicz Z, Sharpless TK, et al: Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood 55:282-293, 1980
24. Nilsson K: The control of growth and differentiation in chronic lymphocytic leukemia (B-CLL) cells, in Cheson BD (ed): Chronic Lymphocytic Leukemia: Scientific Advances & Clinical Development. New York, NY, Marcel Dekker Inc, 1992, pp 33-45
25. Reth M: Antigen receptors on B lymphocytes. Annu Rev Immunol 10:97-121, 1992
26. Zomas AP, Matutes E, Morilla R, et al: Expression of the immunoglobulin-associated protein B29 in B cell disorders with the monoclonal antibody SN8 (CD79b). Leukemia 10:1966-1970, 1996
27. Thompson AA, Talley JA, Do HN, et al: Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. Blood 90:1387-1394, 1997
28. Hashimoto S, Chiorazzi N, Gregersen PK: Alternative splicing of CD79a (Ig-alpha/mb-1) and CD79b (Ig-beta/B29) RNA transcripts in human B cells. Mol Immunol 32:651-659, 1995
29. Koyama M, Nakamura T, Higashihara M, et al: The novel variants of mb-1 and B29 transcripts generated by alternative mRNA splicing. Immunol Lett 47:151-156, 1995
30. Caligaris-Cappio F: The nature of malignant B cells in B-chronic lymphocytic leukemia. Symposium, B Cell Lymphoproliferative Disorders. New York, NY, April 18-21, 1998, pp 47-48
31. Lankester AC, van Schijndel GMW, van der Schoot CE, et al: Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. Blood 86:1090-1097, 1995
32. Cooke MP, Heath AW, Shokat KM, et al: Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med 179:425-438, 1994
33. Michel F, Merle-Beral H, Legac E, et al: Defective calcium response in B-chronic lymphocytic leukemia cells. J Immunol 150:3624-3633, 1993
34. Clark EA, Lane PJL: Regulation of human B-cell activation and adhesion. Annu Rev Immunol 9:97-127, 1991
35. Matutes E, Owusu-Ankomah K, Morilla R, et al: The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8:1640-1645, 1994
36. Rickinson AB, Finerty S, Epstein MA: Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukemic cells. Clin Exp Immunol 50:347-354, 1982
37. Ghigo D, Gaidano GL, Treves S, et al: Na+/H+ antiporter has different properties in human B lymphocytes according to CD5 expression and malignant phenotype. Eur J Immunol 21:583-588, 1991
38. Grinstetn S, Rothstein A: Mechanisms of regulation of the Na+/H+ exchanger. J Membr Biol 90:1-9, 1986
39. Hoffbrand AV, Panayiotidis P, Reittie J, et al: Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Semin Hematol 30:306-317, 1993
40. Pistoia V: Production of cytokines by human B cells in health and disease. Immunol Today 18:343-350, 1997
41. Fluckiger AC, Durand I, Banchereau J: Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia. J Exp Med 179:91-99, 1994
42. Sjober J, Aguilar-Santelises M, Sjogren AM, et al: Interleukin-10 mRNA expression in B-cell chronic lymphocytic leukemia inversely correlates with progression of disease. Br J Haematol 92:393-400, 1996
43. Jurlander J, Lai CF, Tan J, et al: Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood 89:4146-4152, 1997
44. Lotz M, Ranheim E, Kipps TJ: Transforming growth factor β as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J Exp Med 179:999-1004, 1994
45. Buschle M, Campana D, Carding SR, et al: Interferonγ inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 177:213-218, 1993
46. Chaouchi N, Arvanitakis L, Auffredou MT, et al: Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 11:1615-1622, 1995
47. Douglas RS, Capocasale RJ, Lamb RJ, et al: Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-β. Blood 89:941-947, 1997
48. Cordingley FT, Hoffbrand AV, Heslop HE, et al: Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet 1:969-971, 1988
49. Francia di Celle P, Mariani S, Riera L, et al: Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 87:4382-4389, 1996
50. van Kooten C, Rensink I, Aarden L, et al: lnterleukin-4 inhibits both paracrine and autocrine tumor necrosis factor-γ-induced proliferation of B chronic lymphocytic leukemia cells. Blood 80:1299-1306, 1992
51. Trentin L, Zambello R, Agostini C, et al: Expression and regulation of tumor necrosis factor, interleukin-2, and hematopoietic growth factor receptors in B-cell chronic lymphocytic leukemia. Blood 84:4249-4256, 1994
52. Mainou-Fowler T, Copplestone JA, Prentice AG: Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells. J Clin Pathol 48:482-487, 1995
53. Mainou-Fowler T, Prentice AG: Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 21:369-378, 1996
54. Trentin L, Zambello R, Facco M, et al: Interleukin-15: A novel cytokine with regulatory properties on normal and neoplastic B lymphocytes. Leuk Lymphoma 27:35-42, 1997
55. Dancescu M, Rubio-Trujillo M, Biron G, et al: Interleukin 4 protects chronic lymphocytic leukemia from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 176:1319-1326, 1992
56. Panayiotidis P, Ganeshaguru K, Jabbar SA, et al: Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br J Haematol 85:439-445, 1993
57. Reittie JR, Hobbrand AV: Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells. Leuk Res 18:55-60, 1994
58. Panayiotidis P, Ganeshaguru K, Jabbar SA, et al: Alpha-interferon (alpha-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro. Br J Haematol 86:169-173, 1994
59. Lankester AC, van Schijndel GMW, Cordell JL, et al: CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol 24:812-816, 1994
60. Van de Velde H, von Hoegen I, Luo W, et al: The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 351:662-665, 1991
61. Ranheim EA, Cantwell MJ, Kipps TJ: Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 85:3556-3565, 1995
62. Wendel-Hansen V, Sallstrom J, De Campos-Lima PO, et al: Epstein-Barr virus (EBV) can immortalize B-CLL cells activated by cytokines. Leukemia 8:476-482, 1994
63. Oscier DG: Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia. Blood Rev 8:88-97, 1994
64. Que TH, Marco G, Ellis J, et al: Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: Analysis by stage, immunophenotype, and morphology. Blood 82:571-575, 1993
65. Juliusson G, Oscier DG, Fitchett M, et al: Prognostic sub-groups in B-cell chronic lymphocytic leukemia denned by specific chromosomal abnormalities. N Engl J Med 323:720-724, 1990
66. Fitchett M, Griffiths MJ, Oscier DG, et al: Chromosome abnormalities involving band 13q14 in hematologic malignancies. Cancer Genet Cytogenet 24:143-150, 1987
67. Han T, Ozer H, Sadamori N, et al: Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia. N Engl J Med 310:288-292, 1984
68. Dohner H, Stilgenbauer S, Liebisch P, et al: 11q deletions are the second most common chromosome aberration in B cell chronic lymphocytic leukemia and are associated with advanced stages and marked lymphadenopathy. Blood 86:1369a, 1995 (suppl 1)
69. Offit K, Parsa NL, Gaidano G, et al: 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 82:2157-2162, 1993
70. Garcia-Marco JA, Caldas C, Price CM, et al: Frequent somatic deletion of the 13q12 locus encompassing BRCA2 in chronic lymphocytic leukemia. Blood 88:1568-1575, 1996
71. Panayiotidis P, Ganeshaguru K, Rowntree C, et al: Lack of clonal BRCA2 gene deletion on chromosome 13 in chronic lymphocytic leukaemia. Br J Haematol 99:708-709, 1997
72. Corcoran MM, Rasool O, Liu Y, et al: Detailed molecular delineation of 13q14.3 loss in B-cell chronic lymphocytic leukemia. Blood 91:1382-1390, 1998
73. Liu Y, Corcoran MM, Rasool O, et al: Cloning of two candidate tumour suppressor genes within a 10kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia. Oncogene 15:2463-2473, 1997
74. Oscier DG, Stevens J, Hamblin TJ, et al: Correlation of chromosomal abnormalities with laboratory features and clinical course in B cell chronic lymphocytic leukaemia. Br J Haematol 76:352-358, 1990
75. Binet JL, Catovsky D, Chastang C, et al: Prognostic features of early chronic lymphocytic leukaemia. Lancet 2:968-969, 1989
76. Oscier DG, Matutes E, Copplestone A, et al: Atypical lymphocyte morphology: An adverse prognostic factor for disease progression in stage A CLL independent of trisomy 12. Br J Haematol 98:934-939, 1997
77. Tefferi A, Bartholmai BJ, Witzig TE, et al: Clinical correlations of immunophenotypic variations and the presence of trisomy 12 in B-cell chronic lymphocytic leukaemia. Cancer Genet Cytogenet 95:173-177, 1997
78. Matutes E, Oscier DG, Garcia-Marco J, et al: Trisomy 12 defines a group of CLL with atypical morphology: Correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 92:282-288, 1996
79. Merup M, Juliusson G, Wu X, et al: Amplification of multiple regions of chromosome 12, including 12q13-15, in chronic lymphocytic leukaemia. Br J Haematol 58:174-180, 1996
80. Dierlamm J, Wlodarska I, Michaux L, et al: FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial trisomy 12. Genes Chromosom Cancer 20:155-166, 1997
81. Watanabe T, Hotta T, Ichikawa A, et al: The MDM2 oncogene overexpression in chronic lymphocytic leukemia and low grade lymphoma of B-cell origin. Blood 84:3158-3165, 1994
82. Haidar MA, El-Hajj H, Bueso-Ramos CE, et al: Expression profile of MDM-2 proteins in chronic lymphocytic leukemia and their clinical relevance. Am J Hematol 54:189-195, 1997
83. Oscier DG, Thompsett A, Zhu D, et al: Differential rates of somatic hypermutation in VH genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalities. Blood 89:4153-4160, 1997
84. Cuneo A, Balboni M, Piva N, et al: Atypical chronic lymphocytic leukaemia with (t11;14)(q13;q32): Karyotype evolution and prolymphocytic transformation. Br J Haematol 90:409-416, 1995
85. Bosch F, Jares P, Campo E, et al: Prad 1/Cyclin D1 gene overexpression in chronic lymphoproliferative disorders: A highly specific marker for mantle cell lymphoma. Blood 84:2726-2732, 1994
86. Dohner H, Stilgenbauer S, James MR, et al: 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 89:2516-2522, 1997
87. Lens D, Dyer MJ, Garcia-Marco JM, et al: p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. Br J Haematol 99:848-857, 1997
88. Gaidano GL, Ballerini P, Gong JZ, et al: p53 mutations in human lymphoid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413-5417, 1991
89. Dyer MJS, Zani VJ, Lu WZ, et al: BCL2 translocations in leukemias of mature B cells. Blood 83:3682-3688, 1994
90. Pezzella F, Tse AGD, Cordell JL, et al: Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137:225-232, 1990
91. Schena M, Larsson LG, Gottardi D, et al: Growth and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 79:2981-2989, 1992
92. Hanada M, Delia D, Aiello A, et al: Bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820-1828, 1993
93. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the Bcl-2 gene family and cell death. Blood 88:386-401, 1996
94. Chittenden T, Harrington EA, O'Connor R, et al: Induction of apoptosis by the Bcl-2 homologue Bax. Nature 374:733-736, 1995
95. Boise LH, Gonzàles-Garcìa M, Postema CE, et al: Bcl-X, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608, 1993
96. Gottardi D, Alfarano A, De Leo AM, et al: In leukemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis. Br J Haematol 94:612-618, 1996
97. Mapara MY, Bargon R, Zugck C, et al: APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: Correlation with bcl-2 oncogene expression. Eur J Immunol 23:702-708, 1993
98. Larsson LG, Gray HE, Totterman T, et al: Drastically increased expression of MYC and FOS protooncogenes during in vitro differentiation of chronic lymphocytic leukemia cells. Proc Natl Acad Sci USA 84:223-225, 1987
99. Michaux L, Dierlamm J, Wlodarska I, et al: t(14;19)/BCL3 rearrangements in lymphoproliferative disorders: A review of 23 cases. Cancer Genet Cytogenet 94:36-43, 1997
100. Pizzolo G, Chilosi M, Ambrosetti A, et al: Immunohistologic study of bone marrow involvement in B-chronic lymphocytic leukemia. Blood 62:1289-1296, 1983
101. Decker T, Flohr T, Trautmann P, et al: Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia. Blood 86:1115-1123, 1995
102. Keely P, Parise L, Juliano R: Integrins and GTPases in tumour cell growth, mobility and invasion. Trends Cell Biol 8:101-106, 1998
103. Caligaris-Cappio F, Bergui L, Tesio, et al: Cytoskeleton organization is aberrantly rearranged in the cells of B-chronic lymphocytic leukemia and hairy cell leukemia. Blood 67:233-239, 1986
104. Vincent AM, Cawley JC, Burthem J: Integrin function in chronic lymphocytic leukemia. Blood 87:4780-4788, 1996
105. Molica S, Dattilo A, Mannella A, et al: Intercellular adhesion molecules (ICAMs) 2 and 3 are frequently expressed in B cell chronic lymphocytic leukemia. Leukemia 10:907-908, 1996
106. Carlsson M, Soderberg O, Nilsson K: Interleukin-4 (IL-4) enhances homotypic adhesion of activated B-chronic lymphocytic leukaemia (B-CLL) cells via a selective up-regulation of CD54. Scand J Immunol 37:515-522, 1993
107. Csanaky G, Matutes E, Vass JA, et al: Adhesion receptors on peripheral blood leukemic B cells: A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias. Leukemia 11:408-415, 1997
108. Behr SI, Korinth D, Schriever F: Differential adhesion pattern of B cell chronic lymphocytic leukemia cells. Leukemia 12:71-77, 1998
109. De Rossi G, Zarcone D, Mauro F, et al: Adhesion molecule expression on B-cell chronic lymphocytic leukemia cells: Malignant cell phenotypes define distinct disease subsets. Blood 81:2679-2687, 1993
110. Lagneaux L, Delforge A, Bron D, et al: Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 91:2387-2396, 1998
111. Panayiotidis P, Jones D, Ganeshaguru K, et al: Human bone marrow stromal cells prevent apoptosis and support the survival at chronic lymphocytic leukaemia cells in vitro. Br J Haematol 92:97-103, 1996
112. Chilosi M, Pizzolo G, Caligaris-Cappio F, et al: Immunohistochemical demonstration of follicular dendritic cells in bone marrow involvement of B-chronic lymphocytic leukemia. Cancer 56:328-332, 1985
113. Semenzato G, Foa R, Agostini C, et al: High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood 70:396-400, 1987
114. Dazzi F, D'Andrea E, Biasi G, et al: Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. Clin Immunol Immunopathol 75:26-32, 1995
115. Eris JM, Basten A, Brink R, et al: Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions. Proc Natl Acad Sci USA 91:4392-4396, 1994
116. Lanzavecchia A: Antigen-specific interactions between T and B cells. Nature 314:537-539, 1985
117. Cantwell M, Hua T, Pappas J, et al: Acquired CD40-hgand deficiency in chronic lymphocytic leukemia. Nat Med 3:984-989, 1997
118. Hamblin TJ, Oscier DG, Young BJ: Autoimmunity in chronic lymphocytic leukemia. J Clin Pathol 39:713-716, 1986
119. Myint H, Copplestone JA, Orchard J, et al: Fludarabine related autoimmune haemolytic anaemia in patients with chronic lymphocytic leukemia. Br J Haematol 91:341-344, 1995
120. Ranheim EA, Kipps TJ: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med 177:925-935, 1993
121. Kobayashi R, Picchio G, Kirven M, et al: Transfer of human chronic lymphocytic leukemia to mice with severe combined immune deficiency. Leuk Res 16:1013-1018, 1992
122. Schattner EJ, Mascarenhas J, Reyfman I, et al: Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood 91:2689-2697, 1998
123. Efremov DG, Ivanovski M, Siljanovski N, et al: Restricted immunoglobulin VH region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia. Blood 87:3869-3876, 1996
124. Kay NE: Abnormal T cell subpopulation function m CLL: Excessive suppressor and deficient helper activity with respect to B cell proliferation. Blood 57:418-420, 1981
125. Serrano D, Monteiro J, Slet A, et al: Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol 158:1482-1489, 1997